In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1859 News Items found
Can Exercise Impact Prostate Cancer? A First of its Kind Clinical Trial

Learn how exercise may affect the treatment of prostate cancer, in a first of its kind clinical trial at Memorial Sloan Kettering Cancer Center.
Andrea Schietinger
Better Together: Spatial Arrangement of Three Immune Cells Is Key to Attacking Tumors

In order for immune cells to effectively kill cancer cells, a triad of three cells are necessary — a dendritic cell, a cytotoxic “killer” T cell, and a helper T cell, researchers at MSK and Baylor College of Medicine have found. The discovery could alter the way doctors administer immunotherapies.
Ellen Horste
From Basic Science to Biotech: One MSK Alum’s Journey

Learn how GSK graduate Dr. Ellen Horste’s time investigating fundamental biological questions prepared her for a career in the emerging field of gene therapy.
Family of four sitting and smiling for camera.
Metastatic Breast Cancer and Motherhood: Staying Hopeful

Learn how MSK's expertise in metastatic breast cancer helped a mother celebrate a long-awaited milestone with her family.
Pancreatic cancer cells
MSK Discovery Suggests Opportunity to Improve Effectiveness of KRAS Inhibitors Against Pancreatic Cancer

MSK researchers have discovered a new mechanism of resistance to KRAS inhibitors that suggests an opportunity to make the treatment more effective.
Giovanna Whitting
For Thyroid Cancers with RET Mutations, FDA Approves Selpercatinib

The FDA has granted full approval to the targeted therapy selpercatinib (Retevmo®) for treating thyroid cancers that have certain changes in a gene called RET. Learn about MSK’s role in the development of this drug and about how patients may benefit.
Dr. Gaetano Rocco is seen holding a component of the E-nose lung cancer test.
A Potential New Test for Lung Cancer: The Noninvasive E-Nose

Learn about a noninvasive lung cancer test called "E-nose" that is being investigated at Memorial Sloan Kettering.
detail shot of specimen slides
MSK Research Highlights, July 8, 2024

New MSK research developed a deep-learning model designed to aid challenging cancer diagnoses; identified key regulators of infection-clearing immune cells; and shed new light on the mechanical forces exerted by immune cells.
MSK melanoma expert James Smithy, MD
Feature
New Treatments Improving Prognosis for Stage 4 Melanoma Patients

Researchers at MSK have been at the forefront of developing new treatments for advanced melanoma for many years. Learn more about the latest therapies.
Close-up of two people holding hands
Coping With Grief: 7 Things to Remember When Dealing with Loss

Grief can feel all-consuming, but those intense feelings don’t last forever.